Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Condition(s) studied
Investigational drug(s) / intervention(s)
high-precision carotid echo-tracking: evaluation of vascular aging parameters and baroreflex sensitivity
Study summary
The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.
Eligibility
Primary outcome measure(s)
- carotid diameter — by 2027
high precision carotid echo tracking diameter in mm - intima media thickness — by 2027
high precision echo tracking intima media thickness of the common carotid artery in mm - carotid plaques — by 2027
high precision carotid echo tracking carotid plaques - wall cross sectional area — by 2027
high precision carotid echo tracking carotid wall cross sectional area, mm2 - distensibility coefficient — by 2027
high precision carotid echo tracking distensibility coefficient in 10-3/kPa - elastic modulus — by 2027
high precision carotid echo tracking Young's elastic modulus, 10-3\*kPa - pulse wave velocity — by 2027
high precision carotid echotracking pulse wave velocity, m/s - carotid wall stress — by 2027
high precision carotid echotracking circumferential wall stress in kPa - stiffness — by 2027
high precision carotid echotracking Beta stiffness index - pulse pressure — by 2027
high precision carotid echotracking pulse pressure in mmHg
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre d'Investigation Précliniques | Paris | France | Recruiting |
More Institut National de la Santé Et de la Recherche Médicale, France trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06079424 on ClinicalTrials.gov ↗ ← All trials in France